Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_assertion type Assertion NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_head.
- NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_assertion wasGeneratedBy ECO_0000203 NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_provenance.
- NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_assertion wasDerivedFrom befree-20150227 NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_provenance.
- NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_assertion SIO_000772 21622733 NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_provenance.
- NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_assertion evidence source_evidence_literature NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_provenance.
- NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_assertion description "[Given the existence of genes, such as p57(KIP2), which may mediate anti-inflammatory actions of glucocorticoids, we propose that repression of transactivation represents a mechanism for glucocorticoid resistance and for understanding the clinical benefit of LABAs as an add-on therapy in asthma and chronic obstructive pulmonary disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303912.RACGTJwL6wSfI55IdtQQx9fDKXX0v1it2CKeEFg70-VCE130_provenance.